The Anti-Aging Supplement Scam (New Evidence)

Why It Matters

Because most anti‑aging supplements lack reproducible evidence, consumers risk wasting money and health while investors chase hype; rigorous, multi‑site trials remain the only reliable filter for genuine longevity therapies.

Key Takeaways

• ITP rigorously tests anti‑aging compounds across three independent labs.
• Most supplement claims, including Aazanthin and AKG, fail reproducibility.
• Only prescription drugs like rapamycin consistently extend mouse lifespan.
• Human AKG study lacks placebo control and uses imprecise epigenetic clock.
• Consumers should remain skeptical of over‑the‑counter longevity products.

Summary

The video exposes how the Interventions Testing Program (ITP) debunks popular anti‑aging supplement claims by subjecting them to triple‑site mouse trials, highlighting recent findings that overturn hype around products like Aazanthin and calcium‑alpha‑ketoglutarate (AKG).

In 2023 the ITP reported a 12 % median‑lifespan gain for male mice given high‑dose Aazanthin, the strongest result in 14 years. Follow‑up testing at lower doses showed no benefit and even shortened female survival. AKG, once touted to cut biological age by eight years, failed to extend lifespan in two separate cohorts, mirroring earlier null results for resveratrol, fish oil, and fisetin.

The video cites a founder’s press release claiming “longevity escape velocity” based on an epigenetic clock with a ±4‑year error margin and no placebo group—an example of marketing masquerading as science. It also revisits the 2016 nicotinamide riboside hype that collapsed under ITP replication, and the resveratrol saga that cost GSK $720 million before being abandoned.

The takeaway is clear: only a handful of prescription‑level compounds—rapamycin, metformin, 17‑α‑estradiol, and canagliflozin—have survived the ITP’s stringent protocol, and none are available as over‑the‑counter supplements. Consumers and investors should demand multi‑site, placebo‑controlled data before buying anti‑aging products, and focus on proven lifestyle interventions such as exercise.

Original Description

For weekly health research summaries and extra insights, sign up here 👉 https://drstanfield.com/pages/sign-up

💊 Supplements I Take: https://drstanfield.com/pages/my-supplements

💊MicroVitamin+ (Pro) Powder: https://drstanfield.com/products/microvitamin-plus

💊MicroVitamin Standard Capsules: https://drstanfield.com/products/microvitamin

🩺 Get your personalized health roadmap (free): https://drstanfield.com/pages/roadmap

Timestamps:

00:00 The Interventions Testing Program

03:41 The Breakthrough: Rapamycin

05:21 The Excitement Around Astaxanthin and AKG

09:44 The ITP's Latest Results

11:16 Conclusion and Key Takeaways

✔️ X: https://x.com/BradStanfieldMD

✔️ Patreon: https://www.patreon.com/bradstanfieldmd

Here are the links to the research papers referenced in the video:

Astaxanthin/meclizine ITP 2023 — https://link.springer.com/article/10.1007/s11357-023-01011-0

Rejuvant "longevity escape velocity" press release — https://www.globenewswire.com/news-release/2023/03/28/2635803/0/en/67-Year-Old-Founder-of-Ponce-De-Leon-Health-Achieves-Longevity-Escape-Velocity-with-Rejuvant.html

ITP 2026 paper (all 11 compounds fail) — https://link.springer.com/article/10.1007/s11357-026-02201-2

NIA ITP overview — https://www.nia.nih.gov/research/dab/interventions-testing-program-itp

NIA ITP about page (UM-HET3 mice) — https://www.nia.nih.gov/research/dab/interventions-testing-program-itp/about-itp

NR extends lifespan in mice (Zhang 2016) — https://www.science.org/doi/10.1126/science.aaf2693

NR fails ITP (17-a-estradiol paper) — https://pmc.ncbi.nlm.nih.gov/articles/PMC8135004/

Rapamycin discovery (Easter Island) — https://pmc.ncbi.nlm.nih.gov/articles/PMC9494524/

Rapamycin extends lifespan (Harrison 2009, Nature) — https://www.nature.com/articles/nature08221

Science top 10 breakthroughs 2009 — https://www.science.org/doi/10.1126/science.326.5960.1600

ITP supported interventions list — https://www.nia.nih.gov/research/dab/interventions-testing-program-itp/supported-interventions

AKG extends lifespan (Buck Institute 2020) — https://pmc.ncbi.nlm.nih.gov/articles/PMC8508957/

Lithgow quote (Buck press release) — https://www.buckinstitute.org/news/a-metabolite-produced-by-the-body-increases-lifespan-and-dramatically-compresses-late-life-morbidity-in-mice/

Sinclair AKG tweet — https://x.com/davidasinclair/status/1300868036023459841

Rejuvant "8 year" study (Demidenko 2021) — https://www.aging-us.com/article/203736/text

Horvath clock comparison — https://www.mdpi.com/2673-8856/5/2/28

Resveratrol in mice (Sinclair 2006, Nature) — https://www.nature.com/articles/nature05354

GSK acquires Sirtris for $720M — https://www.fiercebiotech.com/biotech/glaxosmithkline-gsk-to-acquire-sirtris-pharmaceuticals-a-world-leader-sirtuin-research-and

Resveratrol not a direct SIRT1 activator — https://pmc.ncbi.nlm.nih.gov/articles/PMC2832984

SRT501 trial halted (kidney damage) — https://www.fiercebiotech.com/biotech/safety-concerns-force-glaxo-to-suspend-enrollment-srt501-trial

GSK shuts down Sirtris — https://www.bioworld.com/articles/438084

Kaeberlein "most debunked" quote — https://www.levels.com/blog/matt-kaeberlein-longevity-science

Astaxanthin skin meta-analysis — https://pmc.ncbi.nlm.nih.gov/articles/PMC8472736/

Thumbnail by James Kelly

Video edited by Troy Young

Script by John Milliken

The links above are affiliate links, so I receive a small commission every time you use them to purchase a product. The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.